From the Journals

From the Journals

Novel AKT inhibitor active against MM cells

The investigational agent showed multiple myeloma-specific cytotoxicity in human cells, and antimyeloma activity in mouse models.

From the Journals

Cell population appears to drive relapse in AML

“Leukemic-regenerating cells,” which are distinct from therapy-naive leukemic stem cells, may be responsible for relapse in acute myeloid leukemia...

Pages